Immune response to biologic scaffold materials

Atala, 2006, Tissue-engineered autologous bladders for patients needing cystoplasty, Lancet, 367, 1241, 10.1016/S0140-6736(06)68438-9 Barber, 2006, Tendon augmentation grafts: biomechanical failure loads and failure patterns, Arthroscopy, 22, 534, 10.1016/j.arthro.2005.12.021 Brigido, 2006, The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16-week pilot study, Int Wound J, 3, 181, 10.1111/j.1742-481X.2006.00209.x Butler, 2004, Reduction of adhesions with composite AlloDerm/polypropylene mesh implants for abdominal wall reconstruction, Plast Reconstr Surg, 114, 464, 10.1097/01.PRS.0000132670.81794.7E Catena, 2005, Lichtenstein repair of inguinal hernia with Surgisis inguinal hernia matrix soft-tissue graft in immunodepressed patients, Hernia, 9, 29, 10.1007/s10029-004-0273-y Coons, 2006, Tendon graft substitutes-rotator cuff patches, Sports Med Arthrosc, 14, 185, 10.1097/00132585-200609000-00011 Harper, 2001, Permacol: clinical experience with a new biomaterial, Hosp Med, 62, 90, 10.12968/hosp.2001.62.2.2379 Lee, 2004, GraftJacket augmentation of chronic Achilles tendon ruptures, Orthopedics, 27, s151, 10.3928/0147-7447-20040102-15 Liyanage, 2005, Anterior abdominal wall reconstruction with a Permacol implant, Br J Plast Surg Metcalf, 2002, Surgical technique for xenograft (SIS) augmentation of rotator-cuff repairs, Oper Tech Orthop, 12, 204, 10.1053/otor.2002.36298 Parker, 2006, Porcine dermal collagen (Permacol) for abdominal wall reconstruction, Curr Surg, 63, 255, 10.1016/j.cursur.2006.05.003 Sclafani, 2000, Evaluation of acellular dermal graft in sheet (AlloDerm) and injectable (micronized AlloDerm) forms for soft tissue augmentation. Clinical observations and histological analysis, Arch Facial Plast Surg, 2, 130, 10.1001/archfaci.2.2.130 Smart, 2007, Laparoscopic repair of a Littre's hernia with porcine dermal collagen implant (Permacol), Hernia, 11, 373, 10.1007/s10029-007-0197-4 Ueno, 2004, Clinical application of porcine small intestinal submucosa in the management of infected or potentially contaminated abdominal defects, J Gastrointest Surg, 8, 109, 10.1016/j.gassur.2003.09.025 Lotze, 2007, Damage-associated molecular pattern molecules, Clin Immunol, 124, 1, 10.1016/j.clim.2007.02.006 Bianchi, 2007, DAMPs, PAMPs and alarmins: all we need to know about danger, J. Leukocyte Biol, 81, 1, 10.1189/jlb.0306164 Gilbert, 2006, Decellularization of tissues and organs, Biomaterials, 27, 3675 Valentin, 2006, Extracellular matrix bioscaffolds for orthopaedic applications. A comparative histologic study, J Bone Joint Surg Am, 88, 2673, 10.2106/JBJS.E.01008 Collins, 1994, Mechanisms of injury in porcine livers perfused with blood of patients with fulminant hepatic failure, Transplantation, 58, 1162 Cooper, 1993, Identification of alpha-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man, Transpl Immunol, 1, 198, 10.1016/0966-3274(93)90047-C Galili, 1985, Human natural anti-alpha-galactosyl IgG. II. The specific recognition of alpha (1–3)-linked galactose residues, J Exp Med, 162, 573, 10.1084/jem.162.2.573 Oriol, 1993, Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation, Transplantation, 56, 1433, 10.1097/00007890-199312000-00031 Galili, 1987, Identification of erythrocyte Gal alpha 1-3Gal glycosphingolipids with a mouse monoclonal antibody, Gal-13, J Biol Chem, 262, 4683, 10.1016/S0021-9258(18)61249-9 Galili, 1988, Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells, J Biol Chem, 263, 17755, 10.1016/S0021-9258(19)77900-9 Spiro, 1984, Occurrence of alpha-d-galactosyl residues in the thyroglobulins from several species. Localization in the saccharide chains of the complex carbohydrate units, J Biol Chem, 259, 9858, 10.1016/S0021-9258(17)42779-7 Thall, 1990, Distribution of Gal alpha 1–3Gal beta 1–4GlcNAc residues on secreted mammalian glycoproteins (thyroglobulin, fibrinogen, and immunoglobulin G) as measured by a sensitive solid-phase radioimmunoassay, Biochemistry, 29, 3959, 10.1021/bi00468a024 Towbin, 1987, Circulating antibodies to mouse laminin in Chagas disease, American cutaneous leishmaniasis, and normal individuals recognize terminal galactosyl(alpha 1–3)-galactose epitopes, J Exp Med, 166, 419, 10.1084/jem.166.2.419 Galili, 1991, Gene sequences suggest inactivation of alpha-1,3-galactosyltransferase in catarrhines after the divergence of apes from monkeys, Proc Natl Acad Sci USA, 88, 7401, 10.1073/pnas.88.16.7401 Joziasse, 1991, Characterization of an alpha 1–3-galactosyltransferase homologue on human chromosome 12 that is organized as a processed pseudogene, J Biol Chem, 266, 6991, 10.1016/S0021-9258(20)89600-8 Gabrielli, 1991, Antibodies to mouse laminin in patients with systemic sclerosis (scleroderma) recognize galactosyl (alpha 1–3)-galactose epitopes, Clin Exp Immunol, 86, 367, 10.1111/j.1365-2249.1991.tb02939.x Galili, 1984, A unique natural human IgG antibody with anti-alpha-galactosyl specificity, J Exp Med, 160, 1519, 10.1084/jem.160.5.1519 Goldberg, 1995, Inhibition of the human antipig xenograft reaction with soluble oligosaccharides, Transplant Proc, 27, 249 Koren, 1992, Heterogeneity of preformed human antipig xenogeneic antibodies, Transplant Proc, 24, 598 Lai, 2002, Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning, Science, 295, 1089, 10.1126/science.1068228 Phelps, 2003, Production of alpha 1,3-galactosyltransferase-deficient pigs, Science, 299, 411, 10.1126/science.1078942 Kuwaki, 2005, Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience, Nat Med, 11, 29, 10.1038/nm1171 Tseng, 2005, Alpha1,3-galactosyltransferase gene-knockout pig heart transplantation in baboons with survival approaching 6 months, Transplantation, 80, 1493, 10.1097/01.tp.0000181397.41143.fa Chen, 2005, Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys, Nat Med, 11, 1295, 10.1038/nm1330 Konakci, 2005, Alpha-Gal on bioprostheses: xenograft immune response in cardiac surgery, Eur J Clin Invest, 35, 17, 10.1111/j.1365-2362.2005.01441.x Stone, 2007, Replacement of human anterior cruciate ligaments with pig ligaments: a model for anti-non-gal antibody response in long-term xenotransplantation, Transplantation, 83, 211, 10.1097/01.tp.0000250598.29377.13 Stone, 1998, Porcine cartilage transplants in the cynomolgus monkey. III. Transplantation of alpha-galactosidase-treated porcine cartilage, Transplantation, 65, 1577, 10.1097/00007890-199806270-00007 Stone, 2007, Anterior cruciate ligament reconstruction with a porcine xenograft: a serologic, histologic, and biomechanical study in primates, Arthroscopy, 23, 411, 10.1016/j.arthro.2006.12.024 McPherson, 2000, Galalpha(1,3)Gal epitope in porcine small intestinal submucosa, Tissue Eng, 6, 233, 10.1089/10763270050044416 LaVecchio, 1995, Enzymatic removal of alpha-galactosyl epitopes from porcine endothelial cells diminishes the cytotoxic effect of natural antibodies, Transplantation, 60, 841, 10.1097/00007890-199510270-00014 Hamadeh, 1992, Human natural anti-Gal IgG regulates alternative complement pathway activation on bacterial surfaces, J Clin Invest, 89, 1223, 10.1172/JCI115706 Yu, 1996, Modulation of natural IgM binding and complement activation by natural IgG antibodies: a role for IgG anti-Gal alpha1-3Gal antibodies, J Immunol, 157, 5163, 10.4049/jimmunol.157.11.5163 Bruggemann, 1987, Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies, J Exp Med, 166, 1351, 10.1084/jem.166.5.1351 Galili, 1993, Interaction of the natural anti-Gal antibody with alpha-galactosyl epitopes: a major obstacle for xenotransplantation in humans, Immunol Today, 14, 480, 10.1016/0167-5699(93)90261-I Michaelsen, 1992, Antibody dependent cell-mediated cytotoxicity induced by chimeric mouse-human IgG subclasses and IgG3 antibodies with altered hinge region, Mol Immunol, 29, 319, 10.1016/0161-5890(92)90018-S Raeder, 2002, Natural anti-galactose alpha1,3 galactose antibodies delay, but do not prevent the acceptance of extracellular matrix xenografts, Transpl Immunol, 10, 15, 10.1016/S0966-3274(01)00044-2 Zheng, 2005, Porcine small intestine submucosa (SIS) is not an acellular collagenous matrix and contains porcine DNA: possible implications in human implantation, J Biomed Mater Res B: Appl Biomater, 73, 61, 10.1002/jbm.b.30170 Derwin, 2006, Commercial extracellular matrix scaffolds for rotator cuff tendon repair. Biomechanical, biochemical, and cellular properties, J Bone Joint Surg Am, 88, 2665, 10.2106/JBJS.E.01307 Gilbert TW, Freund JM, Badylak SF, Quantification of DNA in biologic scaffold materials. JSR (submitted for publication). Gilbert, 2007, Degradation and remodeling of small intestinal submucosa in canine Achilles tendon repair, J Bone Joint Surg Am, 89, 621, 10.2106/JBJS.E.00742 Record, 2001, In vivo degradation of 14C-labeled small intestinal submucosa (SIS) when used for urinary bladder repair, Biomaterials, 22, 2653, 10.1016/S0142-9612(01)00007-2 Bennett, 1985, DNA binding to human leukocytes. Evidence for a receptor-mediated association, internalization, and degradation of DNA, J Clin Invest, 76, 2182, 10.1172/JCI112226 McCoy, 2004, Activation of RAW264.7 macrophages by bacterial DNA and lipopolysaccharide increases cell surface DNA binding and internalization, J Biol Chem, 279, 17217, 10.1074/jbc.M303837200 Kumar, 2005 Ratner, 2004 Badylak, 2002, Morphologic study of small intestinal submucosa as a body wall repair device, J Surg Res, 103, 190, 10.1006/jsre.2001.6349 Strom, 1996, The Th1/Th2 paradigm and the allograft response, Curr Opin Immunol, 8, 688, 10.1016/S0952-7915(96)80087-2 Zhai, 1999, Th1 and Th2 cytokines in organ transplantation: paradigm lost?, Crit Rev Immunol, 19, 155 Abbas, 1996, Functional diversity of helper T lymphocytes, Nature, 383, 787, 10.1038/383787a0 Matsumiya, 1994, Assessment of T-cell subsets involved in antibody production and cell-mediated cytotoxicity in rat-to-mouse cardiac xenotransplantation, Transplant Proc, 26, 1214 Chen, 1996, Prevention of Th1 response is critical for tolerance, Transplantation, 61, 1076, 10.1097/00007890-199604150-00016 Bach, 1997, Accommodation of vascularized xenografts: expression of “protective genes” by donor endothelial cells in a host Th2 cytokine environment, Nat Med, 3, 196, 10.1038/nm0297-196 Chen, 1995, Enhanced type 2 and diminished type 1 cytokines in neonatal tolerance, Transplantation, 59, 933, 10.1097/00007890-199504150-00002 Piccotti, 1997, Are Th2 helper T lymphocytes beneficial, deleterious, or irrelevant in promoting allograft survival?, Transplantation, 63, 619, 10.1097/00007890-199703150-00001 Allman, 2001, Xenogeneic extracellular matrix grafts elicit a TH2-restricted immune response, Transplantation, 71, 1631, 10.1097/00007890-200106150-00024 Allman, 2002, The Th2-restricted immune response to xenogeneic small intestinal submucosa does not influence systemic protective immunity to viral and bacterial pathogens, Tissue Eng, 8, 53, 10.1089/107632702753503054 Badylak, 1994, Comparison of the resistance to infection of intestinal submucosa arterial autografts versus polytetrafluoroethylene arterial prostheses in a dog model, J Vasc Surg, 19, 465, 10.1016/S0741-5214(94)70073-7 Badylak, 2003, Host protection against deliberate bacterial contamination of an extracellular matrix bioscaffold versus Dacron mesh in a dog model of orthopedic soft tissue repair, J Biomed Mater Res B: Appl Biomater, 67, 648, 10.1002/jbm.b.10062 Jernigan, 2004, Small intestinal submucosa for vascular reconstruction in the presence of gastrointestinal contamination, Ann Surg, 239, 733, 10.1097/01.sla.0000124447.30808.c7 Shell, 2005, Comparison of small-intestinal submucosa and expanded polytetrafluoroethylene as a vascular conduit in the presence of gram-positive contamination, Ann Surg, 241, 995, 10.1097/01.sla.0000165186.79097.6c Anderson, 2002, A novel phenotype for an activated macrophage: the type 2 activated macrophage, J Leukocyte Biol, 72, 101, 10.1189/jlb.72.1.101 Gordon, 2005, Monocyte and macrophage heterogeneity, Nat Rev Immunol, 5, 953, 10.1038/nri1733 Mantovani, 2005, Macrophage polarization comes of age, Immunity, 23, 344, 10.1016/j.immuni.2005.10.001 Mosser, 2003, The many faces of macrophage activation, J Leukocyte Biol, 73, 209, 10.1189/jlb.0602325 Feili-Hariri, 2005, Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy, J Leukocyte Biol, 78, 656, 10.1189/jlb.1104631 Mills, 2000, M-1/M-2 macrophages and the Th1/Th2 paradigm, J Immunol, 164, 6166, 10.4049/jimmunol.164.12.6166 Mantovani, 2004, The chemokine system in diverse forms of macrophage activation and polarization, Trends Immunol, 25, 677, 10.1016/j.it.2004.09.015 Stout, 2005, Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences, J Immunol, 175, 342, 10.4049/jimmunol.175.1.342 Badylak SF, Valentin JE, Ravindra A, McCabe G, Stewart-Akers AM. Macrophage phenotype as a determinant of orthobiologic scaffold remodeling. Tissue Eng (submitted for publication). Abraham, 2000, Evaluation of the porcine intestinal collagen layer as a biomaterial, J Biomed Mater Res, 51, 442, 10.1002/1097-4636(20000905)51:3<442::AID-JBM19>3.0.CO;2-4 Jarman-Smith, 2004, Porcine collagen crosslinking, degradation and its capability for fibroblast adhesion and proliferation, J Mater Sci Mater Med, 15, 925, 10.1023/B:JMSM.0000036281.47596.cc van der Laan, 1991, TFE-plasma polymerized dermal sheep collagen for the repair of abdominal wall defects, Int J Artif Organs, 14, 661, 10.1177/039139889101401010 van Wachem, 1994, Tissue regenerating capacity of carbodiimide-crosslinked dermal sheep collagen during repair of the abdominal wall, Int J Artif Organs, 17, 230, 10.1177/039139889401700407 Li, 2004, Low-molecular-weight peptides derived from extracellular matrix as chemoattractants for primary endothelial cells, Endothelium, 11, 199, 10.1080/10623320490512390 Badylak, 2001, Marrow-derived cells populate scaffolds composed of xenogeneic extracellular matrix, Exp Hematol, 29, 1310, 10.1016/S0301-472X(01)00729-9 Zantop, 2006, Extracellular matrix scaffolds are repopulated by bone marrow-derived cells in a mouse model of Achilles tendon reconstruction, J Orthop Res, 24, 1299, 10.1002/jor.20071